SIportfolio

Shoulder Innovations Announces Strategic Partnership with INS to Introduce a Robotic Platform for Shoulder Arthroplasty

News / December 3, 2025

Partnership will Expand Shoulder Innovations’ Disruptive Ecosystem with Advanced Enabling Technology, Complementing Surgeon and Patient Needs in the ASC Shoulder Innovations (NYSE: SI), a cultivate(MD) portfolio company, today announced a strategic partnership with Interventional Systems (INS), a developer of robotic solutions for minimally invasive surgery, to introduce a transformative shoulder-specific micro-robotic solution designed to further […]

Shoulder Innovations Announces Strategic Partnership with INS to Introduce a Robotic Platform for Shoulder Arthroplasty Read More »

Shoulder Innovations Reports Third Quarter 2025 Financial Results and Increases Full-Year Revenue Guidance

News / November 12, 2025

Shoulder Innovations, Inc. (Shoulder Innovations, or the company) (NYSE: SI), a cultivate(MD) portfolio company reported financial results for the third quarter ended September 30, 2025. Third Quarter & Recent Business Highlights “We are very excited about our accelerating momentum through 2025, with first-half year-over-year revenue growth of 37% expanding to 58% in the third quarter,

Shoulder Innovations Reports Third Quarter 2025 Financial Results and Increases Full-Year Revenue Guidance Read More »

Shoulder Innovations Announces Full Commercial Launch of the InSet™ 70 Humeral Stem

Press Release / September 22, 2025

Expansion of the I-Series Humeral Stem Product Line Further Strengthens Robust Shoulder Arthroplasty Portfolio Grand Rapids, MI – September 22, 2025 – Shoulder Innovations, Inc. (NYSE: SI), a cultivate(MD) portfolio company exclusively focused on transforming the shoulder surgical care market, today announced the full commercial launch of the InSet™ 70 Humeral Stem (“InSet™ 70”). The

Shoulder Innovations Announces Full Commercial Launch of the InSet™ 70 Humeral Stem Read More »

Shoulder Innovations Reports Second Quarter 2025 Financial Results

Press Release / September 9, 2025

GRAND RAPIDS, Mich., Sept. 9, 2025 /PRNewswire/ — Shoulder Innovations, Inc. (Shoulder Innovations, or the company) (NYSE: SI), a commercial-stage medical technology company exclusively focused on transforming the shoulder surgical care market, today reported financial results for the second quarter ended June 30, 2025. Recent Business Highlights “We are pleased with both our second quarter performance, which was in-line

Shoulder Innovations Reports Second Quarter 2025 Financial Results Read More »

Shoulder Innovations Stock Debuts on NYSE Under Ticker “SI”

News / July 31, 2025

We’re proud to share that Shoulder Innovations, Inc., a cultivate(MD) portfolio company and leader in shoulder surgical technology, has announced the pricing of its initial public offering of 5,000,000 shares of common stock at $15.00 per share. Shoulder Innovations is now publicly listed on the New York Stock Exchange under the ticker symbol “SI.” This

Shoulder Innovations Stock Debuts on NYSE Under Ticker “SI” Read More »

Shoulder Innovations Announces Closing of $40 Million Series E Equity Financing

Press Release / March 10, 2025

Grand Rapids, MI – March 10, 2025 – Shoulder Innovations, a cultivate(MD) portfolio company, and a leader in shoulder replacement technology, today announced the closing of a $40 million Series E equity financing round. The financing was led by existing investor U.S. Venture Partners (USVP), with support from additional existing investors including Gilde Healthcare Partners, Gilmartin Capital,

Shoulder Innovations Announces Closing of $40 Million Series E Equity Financing Read More »